24 January 2017 - MTPConnect – the Medical Technologies, Biotechnologies and Pharmaceuticals Industry Growth Centre – and Medicines Australia – the membership organisation representing the discovery-driven pharmaceutical industry in Australia – have signed a memorandum of understanding (MoU) to work collaboratively to boost the innovative pharmaceutical industry in Australia.

The collaboration will see the two organisations combining their efforts to champion a sector-led approach to accelerate the growth of the ecosystem, through activities to unify and educate the medical technology, biotechnology, and pharmaceutical (MTP) sector, as well as engage with government to create a positive regulatory environment.

Together, MTPConnect and Medicines Australia will support the innovative medicines and vaccines industry to:

• Develop priorities in areas of competitive advantage that relate to the MTP sector;
  
• Identify opportunities for organisations within the sector to collaborate on R&D by pooling and sharing resources;
  
• Showcase the extraordinary talent of the people that work with our industry; and,
  
• Partner with the Australian Government to enable this sector to thrive and lead economic repair.
  

Read Medicines Australia press release